Tema Cardiovascular and Metabolics ETF (NASDAQ:HRTS) Sees Large Increase in Short Interest

Tema Cardiovascular and Metabolics ETF (NASDAQ:HRTS) saw a large growth in short interest in December. As of December 31st, there was short interest totalling 2,400 shares, a growth of 20.0% from the December 15th total of 2,000 shares. Based on an average daily volume of 15,700 shares, the short-interest ratio is currently 0.2 days.

Tema Cardiovascular and Metabolics ETF Stock Performance

Shares of Tema Cardiovascular and Metabolics ETF stock traded down $0.19 during trading on Friday, hitting $28.70. 10,235 shares of the stock traded hands, compared to its average volume of 12,749. The company has a fifty day moving average price of $30.62 and a two-hundred day moving average price of $32.85. Tema Cardiovascular and Metabolics ETF has a twelve month low of $28.56 and a twelve month high of $36.03. The stock has a market cap of $66.30 million, a P/E ratio of 32.89 and a beta of 0.93.

Tema Cardiovascular and Metabolics ETF Announces Dividend

The firm also recently declared a dividend, which was paid on Thursday, December 12th. Stockholders of record on Wednesday, December 11th were issued a dividend of $0.4693 per share. The ex-dividend date of this dividend was Wednesday, December 11th.

Institutional Investors Weigh In On Tema Cardiovascular and Metabolics ETF

A hedge fund recently raised its stake in Tema Cardiovascular and Metabolics ETF stock. Sterling Investment Advisors Ltd. boosted its holdings in Tema Cardiovascular and Metabolics ETF (NASDAQ:HRTS) by 3.7% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 158,695 shares of the company’s stock after buying an additional 5,605 shares during the period. Tema Cardiovascular and Metabolics ETF makes up about 1.4% of Sterling Investment Advisors Ltd.’s investment portfolio, making the stock its 23rd largest position. Sterling Investment Advisors Ltd. owned about 6.40% of Tema Cardiovascular and Metabolics ETF worth $5,332,000 at the end of the most recent quarter.

About Tema Cardiovascular and Metabolics ETF

The Tema Obesity & Cardiometabolic ETF (HRTS) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that concentrates on companies focused on the treatment of cardiovascular diseases and/or metabolic diseases from companies all around the world. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive.